SM-102 is an ionisable cationic amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). Administration of luciferase mRNA in SM-102-containing LNPs induces hepatic luciferase expression in mice. Formulations containing SM-102 have been used in the development of LNPs for delivery of mRNA-based vaccines.
Cayman Chemical’s SM-102 is distributed in Australia and New Zealand by Sapphire Bioscience.
Online:
www.sapphirebioscience.com
Phone: 02 9698 2022
Phone: 02 9698 2022
Related Products
Biosynth carbohydrates
Within the carbohydrate product range, Biosynth offers tools for glycobiology, chemo-enzymatic...
Cayman Chemical Stem Cell Small Molecule Screening Library
The screening library contains more than 140 small molecules that are known either to induce...
Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)
Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains...
